Beli & Jual UBC Medical Indonesia Tbk. - LABS Hari Ini
Quarterly
Yearly
Income Statement
Revenue
Net Profit
Net Loss
Profit margin %
Q4
’24
Q1
’25
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| Revenue | Rp199,3 M | +34.99% |
| Cost of Revenue | Rp119,58 M | +32.56% |
| Gross Profit | Rp79,72 M | +38.81% |
| General Expenses, Depreciation, Interest | Rp58,24 M | +22.15% |
| Operating Profit | Rp21,48 M | +120.24% |
| Other Income | -Rp3,96 M | -11.3% |
| EBT | Rp17,52 M | +231.26% |
| Taxes | -Rp4,02 M | +71.79% |
| Net Income | Rp13,51 M | +357.5% |
Balance Sheet
Assets
Liabilities
Debt to Asset %
Q4
’24
Q1
’25
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| Total Assets | Rp228,19 M | +12.08% |
| Total Liabilities | Rp75,72 M | +16.78% |
| Total Equity | Rp152,46 M | +9.88% |
| Total Liabilities & Total Equity | Rp228,19 M | +12.08% |
Cash Flow
Operating
Investing
Finance
Net CF
Q4
’24
Q1
’25
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| CF from Operations | Rp22,89 M | -267.33% |
| CF from Investment | Rp14,25 M | +107.84% |
| CF from Financing | Rp10,03 M | -116.87% |
| Net Cash Flow | Rp1,39 M | -103.57% |